BR Research

Spike in fuel prices trims GSK profits

Published October 25, 2011 Updated October 25, 2011 12:00am

=====================================================
GlaxoSmithKline
=====================================================
(Rs mn)                   3QCY11     3QCY10       chg
=====================================================
Net Sales                  5,279      4,658       13%
Cost of sales              3,821      3,477       10%
Gross Profit               1,457      1,180       23%
Selling, marketing &
 distribution expenses       810        554       46%
Administrative expenses      171        203      -16%
PAT                          236        273      -14%
EPS (Rs)                    0.99       1.14          
=====================================================

Source: KSE notice